Related Experiment Video
Updated: May 26, 2026

09:38
Generalized Psychophysiological Interaction (PPI) Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
Published on: November 14, 2017
Peripheral TARC (CCL17) Levels Track Widespread Microstructural Vulnerability in Cognitively Unimpaired Older African
Medrxiv : the Preprint Server for Health Sciences
|May 25, 2026
Summary
Elevated TARC levels in older African Americans correlate with early brain microstructural changes, suggesting diffusion MRI can detect Alzheimer's disease risk. This highlights the importance of inflammatory biomarkers in neuroimaging research.
Area of Science:
- Neuroscience
- Immunology
- Radiology
Background:
- Neuroinflammation and immune dysregulation are early drivers of Alzheimer's disease and AD-related dementias (AD/ADRD).
- Non-invasive biomarkers are needed to capture early AD/ADRD processes, especially in underrepresented African American populations.
- This study investigated systemic inflammation and brain microstructure in cognitively unimpaired older African Americans.
Purpose of the Study:
- To examine the relationship between plasma inflammatory markers and brain microstructural integrity.
- To identify potential non-invasive biomarkers for early AD/ADRD detection in African Americans.
- To assess the utility of diffusion MRI in detecting inflammation-related brain changes.
Main Methods:
- Forty-one cognitively unimpaired older African Americans underwent MRI and plasma inflammatory marker quantification.
- Diffusion Weighted Imaging (DWI) metrics (MD, RD, MK, RK) assessed brain microstructure.
- Voxel-wise and cluster-based general linear models analyzed associations between plasma markers and brain metrics.
Main Results:
- Higher TARC levels were linked to increased mean diffusivity (MD) and radial diffusivity (RD) in gray and white matter, indicating reduced microstructural integrity and potential myelin disruption.
- Kurtosis metrics (MK, RK) showed weaker, more selective associations, primarily decreases in white matter tracts.
- Cluster analyses confirmed diffusivity findings and consistent effect sizes across regions.
Conclusions:
- Elevated TARC is associated with early microstructural alterations detectable by diffusion MRI.
- Diffusivity metrics are more sensitive to inflammation-related changes than kurtosis measures in this cohort.
- Diffusion MRI and inflammatory biomarkers are promising for detecting early AD/ADRD neurobiological signatures in African Americans.
Related Concept Videos
Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Cognitive Development During Adulthood
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...

